Jasper Therapeutics, Inc. · NASDAQ:JSPR
Velan Capital Investment Management LP reported a 9.60% stake in Jasper Therapeutics, Inc. (Schedule 13D/A)
Event Sep 19, 2025 · Filed Sep 23, 2025
Velan Capital Investment Management LP reported a 9.60% stake in Jasper Therapeutics, Inc., 2,668,395 shares, with active intent on Sep 19, 2025. Filed Sep 23, 2025 (Schedule 13D/A).
- Stake
- 9.60%
- Shares
- 2,668,395
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 12 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Velan Capital Master Fund LP | 8.50% | 2,381,915 |
| Velan Capital Holdings LLC | 8.50% | 2,381,915 |
| Velan Horizon Fund LP | 0.10% | 41,152 |
| Velan Horizon GP LLC | 0.10% | 41,152 |
| Avego Healthcare Capital, L.P. | 0.90% | 245,328 |
| Avego Healthcare Capital Holdings, LLC | 0.90% | 245,328 |
| Avego Management LLC | 0.90% | 245,328 |
| Velan Capital Investment Management LP | 9.60% | 2,668,395 |
| Velan Capital Management LLC | 9.60% | 2,668,395 |
| Morgan Adam | 9.60% | 2,668,395 |
| VENKATARAMAN BALAJI | 9.60% | 2,668,395 |
| Kapoor Vishal | 0.10% | 23,867 |
Source
Related
- Jasper Therapeutics, Inc.
- Velan Capital Investment Management LP
- Jasper Therapeutics, Inc. shareholders
- Schedule 13G · Velan Capital Investment Management LP · Aug 17, 2026
- Schedule 13D/A · Velan Capital Investment Management LP · Jul 20, 2026
- Schedule 13G/A · Millennium Management LLC · Jul 10, 2026
- Schedule 13G/A · Morgan Stanley · May 12, 2026
- Schedule 13G/A · Goldman Sachs Group Inc · May 8, 2026
- Schedule 13G/A · Soleus Capital Master Fund, L.P. · May 8, 2026
- Schedule 13G · Millennium Management LLC · Feb 25, 2026